RIFAXIA-550 TABLETS

Product Details :

Feature	Details
Product Name	RIFAXIA-550 Tablets
Form	Tablets
Key Ingredient	Rifaximin 550 mg
Core Benefits	Treats hepatic encephalopathy, IBS-D, traveler’s diarrhea
Mechanism of Action	Inhibits bacterial RNA synthesis; acts locally in the gastrointestinal tract
Support Areas	Liver disease, digestive infections, bowel disorders
Recommended Usage	As directed by a physician; commonly twice daily for hepatic use
Target Audience	Adults with chronic liver disease or digestive infections
Packaging Type	Blister pack
Available Pack Sizes	10x1x10 tablets

omposition: Rifaximin 550mg Packing: 10X10 Alu-Alu

Description : RIFAXIA-550 Tablets contain Rifaximin 550 mg, a non-absorbable broad-spectrum antibiotic primarily used to treat hepatic encephalopathy, irritable bowel syndrome with diarrhea (IBS-D), and traveler’s diarrhea caused by non-invasive E. coli. It works locally in the intestines to reduce harmful bacteria and toxins without affecting systemic immunity. RIFAXIA-550 is well-tolerated, causes minimal resistance, and is ideal for long-term gut-related conditions under medical supervision. It helps improve brain function in liver disease and reduces recurrence of hepatic encephalopathy episodes.